Long-Acting HIV Treatment: Current and Future Options
Author:
- 6 March 2025
- journal article
- research article
- Published by Springer Nature in Current Infectious Disease Reports
- Vol. 27 (1) , 1-10
Abstract
No abstract availableKeywords
This publication has 153 references indexed in Scilit:
- Susceptibility to lenacapavir, fostemsavir and broadly neutralizing antibodies in French primary HIV‐1 infected patients in 2020–2023Journal of Medical Virology, 2024
- Implementation of long‐acting cabotegravir and rilpivirine: primary results from the perspective of staff study participants in the Cabotegravir And Rilpivirine Implementation Study in European LocationsJournal of the International AIDS Society, 2024
- Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral TherapyAIDS and Behavior, 2024
- U.S. patient preferences for long‐acting HIV treatment: a discrete choice experimentJournal of the International AIDS Society, 2023
- A phase I, first‐in‐human study investigating the safety, tolerability, and pharmacokinetics of the maturation inhibitor GSK3739937Pharmacology Research & Perspectives, 2023
- Acceptance Rate and Reasons for Rejection of Long Acting Injectable AntiretroviralsAIDS and Behavior, 2022
- Perspectives of people living with HIV‐1 on implementation of long‐acting cabotegravir plus rilpivirine in US healthcare settings: results from the CUSTOMIZE hybrid III implementation‐effectiveness studyJournal of the International AIDS Society, 2022
- Perspectives of healthcare providers on implementation of long‐acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation‐effectiveness study (CUSTOMIZE)Journal of the International AIDS Society, 2022
- Long‐acting and extended‐release implant and nanoformulations with a synergistic antiretroviral two‐drug combination controls HIV‐1 infection in a humanized mouse modelBioengineering & Translational Medicine, 2021
- A Conjoint Analysis of the Acceptability of Targeted Long-Acting Injectable Antiretroviral Therapy Among Persons Living with HIV in the U.S.AIDS and Behavior, 2019